Studies of dopaminergic system, particularly in diagnosis of parkinson's disease.

Iodine (123I) β-CIT injection

Sterile solution for intravenous injection containing [123I]2ß-carbomethoxy-3ß-(4-iodophenyl) tropane in isotonic phosphate buffer. The product is under experimental use, and does not have marketing authorization yet. Toxicology and clinical usefullness has not been fully evaluated. Product is available only in Finland.

Indications

Studies of dopaminergic system, particularly in diagnosis of parkinson's disease.

Manufacturer

MAP Medical Technologies Oy
Tikkakoski, Finland

Adult

Adult dosage I.V. 185 MBq at injection time.

Availability

On tuesdays and wendesdays. Calibration on tuesdays and wednesdays at 17.00 CET.

Expiracy

6 hours after calibrations. Shown in the labels.

Volume

5 ml

Package Sizes

110 MBq/Vial.

Storage

At room temperature, do not freeze.

123I

T1/2 = 13.2 h
γ = 159 keV (83%)

Radioactive Concentration

25 MBq/ml at calibration time.

Specific Activity

> 1000 GBq/µmol

Radiation Dosimetry

Effective dose equivalent (adults) 0.050 mSv/MBq.

Radiochemical Purity

≥ 90 % AS [123I]-β-CIT

Radionuclidic Purity

≥ 99.8% 123I(121Te ≤ 0.2%)

pH

6.0 - 8.0

Not yet available.

Order Form

* Required information
** Only if same calibration date

Product *
Required information

Activity *
Required information

Calibration Date (dd.mm.yy) *
Required information

Number of Doses / Pieces * / **
Required information

Special Requirements
Invalid Input

Order Number
Invalid Input

Hospital *
Required information

Contact Person *
Required information

Email *
Invalid Input

Phone *
Required information

Fax
Invalid Input

Notes
Invalid Input

Orders by phone and email

+358 14 334 5212This email address is being protected from spambots. You need JavaScript enabled to view it.